Irhythm Holdings Inc (IRTC) 13F Investor Activity Report (Q2 2026)

IRTC ranks #2063 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

307 institutions disclose a position in IRTC, but none treat it as a major bet — even Braidwell LP, its most concentrated holder, allocates just 2.9% of its own portfolio to it.

Braidwell LP has added to its IRTC position for two straight quarters, increasing it by $39.3M to reach $77.8M today.

Capital Research Global Investors has trimmed its IRTC position for two straight quarters, cutting it by $170.3M while still holding $39.9M.

IRTC is up 3.4% today, and institutions have been net buyers of $670.4M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

IRTC reported a net loss of $13.9M over the trailing twelve months.

• Not yet profitable — net loss of $13.9M over the trailing twelve months
• Revenue grew 25.6% year over year
• Net income improved year over year, from -$92.4M to -$13.9M
• Generated $80.9M in positive operating cash flow
• Current ratio of 4.63x — enough short-term assets to cover short-term liabilities
• Liabilities run 5.68x equity — a highly leveraged balance sheet worth noting